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The T cell receptor subsets of lymphocytes in 
bronchoalveolar lavage in patients with active 
pulmonary tuberculosis 
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Y. H. KIM* AND C. S. PARK*+ 
“Division of Allergy and Pulmonary Medicine, and ‘Department of Infernal Medicine, 
Hyonam Kidney Laboratory, Soon Chun Hyang University, Seoul, Korea 
study objective. To determine whether or not the levels of y/6 lymphocytes increase in bronchoalveolar lavage 
(BAL) fluid from patients with pulmonary tuberculosis. 
Design. Prospective data collection relating to cells in BAL fluid and peripheral blood mononuclear cells (PBMC) 
from patients with pulmonary tuberculosis and control subjects. 
Setting. A university hospital, from March 1990 to December 1993. 
Patients. Thirteen patients with pulmonary tuberculosis who were diagnosed by culture of Mycobacterium 
tuberculosis from their sputum of BAL fluid and/or clinical response were enrolled in the study. Fifteen healthy 
volunteers participated as control subjects. 
Measurements and results. The differential cell counts in BAL fluid were made by Diff-Quik stain. The percentages 
of T-cell receptor (TCR) (y/6 and u/p)-positive lymphocytes and interleukin 2 (IL-2) receptor-positive CD3 
lymphocytes in BAL fluid and peripheral blood were measured by dual scan with flow-cytometry. The percentage 
and absolute number of lymphocytes and the percentages of CD3’, IL2R’ lymphocytes in BAL fluid significantly 
increased in patients with tuberculosis when compared with those of control subjects. The percentages and numbers 
of y/S and aI/3 TCR-positive lymphocytes in BAL fluid and PBMC from patients with tuberculosis and 
indistinguishable from those of control subjects. 
Conclusions. y/S Lymphocytes do not appear to have as much meaning in patients as they do in animal studies. 
RESPIR. MED. (1998) 92, 408-414 
Introduction 
The immunology of pulmonary tuberculosis is a compli- 
cated matter and is not clearly understood. However, T 
lymphocytes are involved in cell-mediated immune reac- 
tions in the pathogenesis of pulmonary tuberculosis by 
secreting various cytokines and chemotactic materials (1). 
The activation of lymphocytes may be confirmed indirectly 
by the elevated number of soluble interleukin 2 receptors in 
peripheral blood from patients with active pulmonary 
tuberculosis (2). 
Most T lymphocytes recognize antigens through the T 
cell receptor (TCR), which is composed of alp and y/6 
chains (3). The alp receptor-bearing lymphocytes (alp 
lymphocytes) have CD4 and CD8 cell-surface molecules 
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which are involved in the major histocompatibility com- 
plex. In contrast to a/P cells, the y/S receptor-bearing 
lymphocytes (y/6 lymphocytes) do not have CD4 and CD8 
molecules. The y/6 lymphocytes are thought to be the first 
defence mechanism in immunity (4). The elevation of 
CD4 -, CD8 ~ T lymphocytes in pleural fluid from patients 
with tuberculous pleurisy suggested that the y/S lym- 
phocytes act as defence mechanisms against Mycobacterium 
tuberculosis (M. tuberculosis) (5). Recently, Ito et al. 
reported that the number of y/S lymphocytes increased in 
peripheral blood from patients with active pulmonary 
tuberculosis (6). However, the target organ of pulmonary 
tuberculosis is not peripheral blood but the lungs. The 
lymphoblast transformation to purified protein derivatives 
was depressed in peripheral blood, but higher in pleural 
fluid from patients with tuberculous pleurisy, which was 
explained by the phenomenon of sequestration (7). To the 
present authors’ knowledge, no one has yet measured the 
level of y/S lymphocytes in BAL fluid from patients with 
pulmonary tuberculosis. The previous data suggest that it is 
important to measure the level of y/S lymphocytes in 
bronchoalveolar lavage (BAL) fluid, which mirrors the cell 
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composition of target organs in patients with pulmonary 
tuberculosis. 
The present study investigated the level of y/6 lym- 
phocytes in BAL fluid from patients with active pulmonary 
tuberculosis, comparing that level with those in peripheral 
blood and that in BAL fluid from normal subjects. 
Materials and Methods 
PATIENTS 
Thirteen patients with active pulmonary tuberculosis, four 
females and nine males, were included in this study after 
informed consent was obtained. Their ages ranged from 23 
to 60 years. Of these 13, 11 were later diagnosed by M. 
tuberculosis culture and two by positive smear of acid-fast 
bacilli (AFB) with good clinical and radiological response 
to antituberculous chemotherapy. They denied having 
had any previous history of pulmonary tuberculosis and 
chemotherapy. 
Fifteen healthy non-smoking volunteers consisting of 14 
males and one female were also included in this study after 
giving informed consent. They had no respiratory symp- 
toms for at least 1 month prior to the study, and their chest 
radiographs were normal. Their ages ranged from 27 to 31 
years. 
METHODS 
The isolation of peripheral blood mononuclear cells 
(PBMC) was performed on the day of bronchoscopy by 
the density gradient method as previously described (8). 
Briefly, 10 ml heparinized peripheral blood, diluted with 
phosphate-buffered salts (PBS) solution, was centrifuged on 
the Ficoll-hypaque solution. The PBMC were washed twice 
with Ca2’ and Mg2+ -free Hank’s balanced salt solution 
(HBSS) and suspended in HBSS containing 0.1% bovine 
serum albumin and 0.2% sodium azide. Flow-cytometric 
analysis was performed by the description below. 
Bronchoalveolar lavage was carried out by one operator 
as previously described (9). The premeditation was with 
diazepam and atropine. The procedure was performed by 
instilling 50 ml normal saline four times in the most affected 
lung, which was determined by chest X-ray. Negative 
pressure below 50 mmHg was applied for suction under 
fiberoptic bronchoscopy (Olympus B2-10; Olympus Optical 
Co., Tokyo, Japan). Cell pellets and supernatants were 
separated by centrifugation at 500 g for 5 min. A differen- 
tial cell count up to 500 cells was done on slides prepared by 
cytocentrifuge and Diff-Quik stain (Scientific products, 
Gibbstowne, USA). 
BAL cells were washed twice with Ca2+- and Mg2+-free 
HBSS and suspended in HBSS containing 0.1% bovine 
serum albumin and 0.2% sodium azide. Specific bind- 
ing of monoclonal antibodies (mAbs) was analysed by 
dual immunofluorescence staining according to standard 
methods recommended by Becton-Dickinson Monoclonal 
Center (Mountain View, USA). Aliquots containing 1 x lo6 
cells were incubated for 30 min at 4°C in the presence 
of saturating concentrations of fluorescein isothiocyanate 
(FITC) and phycoerythrin-conjugated mAbs. mAbs for 
CD3 (anti-Leu-4) in conjugated form with FITC and CD25 
(anti-Tat), anti-TCR-yl, anti-TCRl in conjugated form 
with phycoerythrin were obtained from Becton Dickinson. 
The cells were washed in PBS solution and fixed in 1 ml of 
1% paraformaldehyde in PBS solution. 
Cytofluorometric analysis of the cells for the sur- 
face immunofluorescence was performed with FACScan 
(Becton-Dickinson). The cells were excited with a 488 nm 
argon laser. The filter set used to separate the two signals 
was recommended by the manufacturer for FITC and 
phycoerythrin. For each sample 1 x lo4 cells were analysed. 
The data were collected and analysed on the Consort 40 
program (Becton-Dickinson). 
STATISTICAL ANALYSIS 
The comparisons between the cellular compositions of 
the patients with pulmonary tuberculosis and the control 
group and between BAL fluid and PBMC were made by 
the Mann-Whitney U test and Wilcoxon rank sum test, 
respectively. All data are expressed as mean f SEM with 
P values ~0.05 being considered statistically significant. 
Results 
The detailed profiles of BAL fluid from the patients and 
healthy studied subjects are shown in Table 1 and Table 2. 
The lavage site was the right upper lobe in nine cases, right 
lower lobe in three cases, and right middle lobe in one case. 
The recovered lavage volume was not different between 
patients with tuberculosis and control subjects (102 f 3.7 
vs. 110 f 6.6 ml, P>O.O5). However, total cell numbers in 
1 ml of BAL fluid and the percentage and absolute number 
of lymphocytes in 1 ml of BAL fluid significantly increased 
in patients with tuberculosis when compared with those 
of control subjects. The percentage of macrophages was 
decreased in patients with tuberculosis when compared with 
those of control subjects although the absolute numbers 
were increased. The composition of neutrophils did not 
show any difference between in-patients with tuberculosis 
and control subjects (Table 3). 
The percentages of CD3+ lymphocytes in BAL fluid from 
patients with tuberculosis and control subjects were 
74.9 f 2.6% and 85.4 Z!Z 7.5%, which were higher (PcO.05) 
than those in PBMC (58.6 & 2.8% and 59.4 f 4.1%, respect- 
ively). The percentage of CD3’ lymphocytes in BAL fluid 
was higher in patients with tuberculosis than it was in 
control subjects in BAL fluid (Fig. 1). The percentages of 
CD3’, IL2R+ lymphocytes in either BAL fluid or PBMC 
were higher in patients with tuberculosis than they were in 
control subjects. However, the percentages were not differ- 
ent between BAL fluid (12.65 i 7.01%) and PBMC 
(3.34 f 1.19%) (Fig. 2). 
The percentages of y/6 lymphocytes in BAL fluid and 
PBMC from patients with tuberculosis were 3.23 It 0.78% 
and 7.61 * 2,06%, which was indistinguishable from con- 
trol subjects (6.9 f 0.93% and 9.52 f 1.72%, respectively). 
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TABLE 2. BAL findings in healthy subjects* 
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Number Age Sex 
Recovered 
volume 
(ml) 
Total 
cell count Macrophage Lymphocyte Neutrophil 
(X lo4 ml-‘) (x lo4 ml-‘, “A) (x104mll’,%) ( X lo4 ml-‘, %) 
1 21 M 100 12 9.0 (75) 2.9 (23.9) 0.1 (1.1) 
2 31 M 95 21 18.6 (89) 2.3 (11.0) 0.1 (0.3) 
3 28 M 94 13 11.1 (85) 1.8 (13.7) 0.2 (1.2) 
4 28 F 160 9 8.3 (92) 0.3 (3.8) 0.3 (3.5) 
5 29 M 104 16 14.2 (89) 1.6 (10.0) 0.2 (1.4) 
6 30 M 85 20 17.4 (87) 2.0 (9.8) 0.7 (3.4) 
I 31 M 120 23 21.7 (94) 0.3 (1.5) 0.9 (4.0) 
8 27 M 105 23 21.6 (94) 0.9 (3.9) 0.5 (2.1) 
9 21 M 120 16 11.3 (70) 4.6 (28.9) 0.1 (0.5) 
10 28 M 136 21 19.7 (94) 0.8 (3.7) 0.5 (2.5) 
11 29 M 130 4 3.6 (90) 0.4 (8.9) 0.1 (1.3) 
12 31 M 85 6 5.6 (93) 0.3 (4.6) 0.1 (2.4) 
13 29 M 140 8 7.7 (97) 0.2 (2.1) 0.1 (1.2) 
14 31 M 56 45 42.5 (95) 1.8 (4.0) 0.7 (1.5) 
15 29 M 125 16 15.1 (94) 0.3 (1.8) 0.6 (3.9) 
*All subjects are non-smokers. Instilled volume is 200 ml and the lavage site is right middle lobe in all cases. 
TABLE 3. The summary of cellular profiles in patients with tuberculosis and healthy subjects 
Healthy subjects Tuberculosis P value 
Total cell count ( x lo4 ml - ‘) 16.9 f 2.5 39.0 zk 5.1 co.05 
Macrophages 
Number ( x lo4 ml ~ ‘) 15.2 zt 2.3 22.6 ct 3.6 co.05 
Percentage 89.2 zk 1.9 51.3 ck 5.4 co.05 
Lymphocytes 
Number ( x lo4 ml - ‘) 1.4 f 0.3 15.0 f 3.5 co.05 
Percentage 8.8 f 2.0 39.2 f 5.5 co.05 
Neutrophils 
Number ( x lo4 ml-‘) 2.0 * 0.3 2.5 f 0.6 ns. 
Percentage 0.3 * 0.1 1.0 f 0.3 ns. 
n.s. = not significant, 
Differences were not seen when comparing the percentages 
in BAL fluid and peripheral blood in patients with 
tuberculosis and control subjects (Fig. 3). The absolute 
number of y/6 lymphocytes per millilitre, which was 
obtained from the percentage of lymphocytes in BAL fluid 
multiplied by the cell number per millilitre of BAL fluid 
increased significantly in patients with tuberculosis 
(3554 f 765 ml-‘) when compared with that of control 
subjects (874 & 240 ml - i) (Fig. 4). 
There were no significant differences between patients 
with pulmonary tuberculosis and healthy subjects in the 
percentages of CL/~ lymphocytes in BAL fluid and those in 
PBMC. However, the absolute count of a//3 lymphocytes in 
BAL fluid was significantly higher in patients with pulmon- 
ary tuberculosis than in healthy subjects (Fig. 4). The ratio 
of composition of a/I/$ lymphocytes was significantly 
higher in patients with pulmonary tuberculosis than in 
healthy subjects (Fig. 5). 
Discussion 
This study showed that the percentage of $6 lymphocytes in 
BAL fluid from patients with active pulmonary tuberculosis 
was not different from that of healthy volunteers. This 
finding is in distinction to those showing increased numbers 
of activated CD3’, al,!?-TCR ~ (suggesting y/6 lymphocyte) 
after exposure of aerosols containing M. tuberculosis in 
mice (10) and increased expression of y/S TCR after 
co-culture with M. tuberculosis and lymphocytes in patients 
with protective immunity (tuberculin reactors and tubercu- 
lous pleuritis) (11). This discrepancy may be related to the 
interval between the exposure of M. tuberculosis and 
the time of study. In animal studies (10,l l), the exact time 
the animals were exposed to M. tuberculosis could be 
determined; however, in this study, determining the exact 
time of exposure to M. tuberculosis was not possible. Inoue 
et al. (12) reported that peritoneal exudate cells expressing 
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FIG. 1. The percentages of CD3’ lymphocytes in BAL 
fluid and PBMC from control subjects (open bar) and 
patients with tuberculosis (hatched bar). *P<O.O5 vs. 
PBMC; ‘WO.05 VS. the control subjects. 
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FIG. 2. The percentages of CD3’, IL2R+ lymphocytes in 
BAL fluid and PBMC from control subjects and patients 
with tuberculosis. The symbols are the same as those in 
Fig. 1. 
y/S TCR decreased gradually, from 7 to 28 days, after 
exposure of BCG. In addition, Ohga et al. (13) described 
the sequential appearance of y/6 and a/p-bearing T-cells 
during infection with Listeria monocytogenes. They ob- 
served the peak level of y/y chain gene on day 3 and of a//3 
chain gene on day 8 after exposure to L. monocytogenes. By 
these findings, they suggested that y/S T-cells precede the a/P 
T-cells in appearance during Listeria infection. Although 
IV. tuberculosis differs from L. monocytogenes in terms of 
antigen, y/S lymphocytes act as a primary immune response 
to certain micro-organisms (14). This sequential appearance 
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FIG. 3. The percentages of y/6 lymphocytes in BAL fluid 
(solid circle) and PBMC (solid square) from patients with 
tuberculosis and control subjects. 
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FIG. 4. The absolute number of y/S lymphocytes in BAL 
fluid from patients with tuberculosis and control subjects. 
The asterisk denotes PcO.05 vs. control subjects. 
of aI/3 and y/S lymphocytes may explain our result. Further- 
more, the vast majority of infiltrating lymphocytes were al/? 
rather than y/S lymphocytes in granulomata from patients 
with tuberculous lymphadenitis (15). Tazi et al. (16) 
observed that the proportion and absolute number of 
circulating y/6 lymphocytes are not different when compar- 
ing blood from patients with tuberculosis and control 
subjects. These results support our findings. Therefore, it is 
possible to say that, in instances when the exact time of 
exposure to antigen cannot be identified, such as this 
clinical study, y/S lymphocytes do not increase because of 
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FIG. 5. The ratio of a/?/$ lymphocytes in BAL fluid from 
patients with tuberculosis and control subjects. *P<O.O5 
vs. control subjects. 
the switching of y/S lymphocytes to alp lymphocytes. The 
other possible causes of the discrepancy might be species 
differences and kinetic factors in terms of primary immu- 
nization and secondary reaction (16). In addition, it is 
difficult to say that the y/6 lymphocytes have important 
roles in the pathogenesis of pulmonary tuberculosis by the 
finding of elevated absolute numbers of y/S lymphocytes in 
BAL fluid from patients with pulmonary tuberculosis, 
because patients with tuberculosis had an elevated level of 
the ratio of a/J/$ lymphocytes and absolute number of up 
lymphocytes. These findings suggest that they may be 
switching from $ to up lymphocytes in vivo. 
It is very important to compare the cellular composition 
between the radiographically normal and abnormal sites in 
the same individual for understanding the local cellular 
response to M tuberculosis. However, in this study, it was 
impossible to perform the BAL at diseased and healthy sites 
because of ethical problems and difficulty in getting 
informed consent from patients and volunteers. Thus, fur- 
ther researches should include the BAL at the normal and 
abnormal sites for the evaluation of cellular response to 
M. tuberculosis. 
We found the composition of IL-2R-expressing lympho- 
cytes in BAL fluid was higher than that in PBMC in healthy 
subjects, suggesting that the cells are activated in normal 
lung. This finding is consistent with the high proportion of 
HLA-DR-positive T cells in normal lavage fluid (17) and 
higher expression of IL-2R and HLA-DR in CD4’ and 
CD8+ BAL T cells than in blood T cells (18). Although the 
‘activation’ of lymphocytes in BAL fluid in control subjects 
might reduce the significance of the ‘activation’ of cells in 
patients with pulmonary tuberculosis, we neglected the 
activation of lymphocytes in control subjects because the 
proportion of IL-2R-expressing lymphocytes in healthy 
subjects was lower than that in patients with pulmonary 
tuberculosis. 
Smoking induced alveolar cellular responses resulting in 
the elevation of the number of alveolar cells, predominantly 
macrophages. In contrast to macrophages, the absolute 
number and subtypes of lymphocytes was not statistically 
different between non-smokers and smokers (19). These 
findings may suggest that smoking itself did not affect the 
analysis of results in this study because we have focused on 
the lymphocytes. 
If diseases are localized, as evidenced by focal infiltrates 
in patients with interstitial lung diseases, the cellular pro- 
files of lavage fluid can show different results (20). By these 
findings, in this study, the bronchoalveolar lavage had to be 
performed at the most affected lesion, mainly the right 
upper lobe, which is the predisposing target of pulmonary 
tuberculosis. The BAL cellular composition of neutrophils 
and eosinophils was not dependent on the lavage site in 
normal subjects (21), and the differences were not observed 
in the cell components of macrophages, neutrophils and 
lymphocytes in patients with pulmonary sarcoidosis (22). 
Thus, we performed the lavage in the right middle lobe 
instead of the right upper lobe in normal controls because 
of easy access and no interlobar cellular differences. 
In summary, we have shown that lavaged alveolar 
lymphocytes express higher IL-2R levels, but do not show 
higher levels of y/6 lymphocytes in patients with pulmonary 
tuberculosis than in control subjects. y/6 lymphocytes do 
not appear to have as much meaning in patients as in the 
animal studies. 
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